Link Biologics Completes IND-Enabling Preclinical Programme for LB001
Link Biologics says it completed IND-enabling preclinical work for its dry eye disease therapy LB001.
Link Biologics says it completed IND-enabling preclinical work for its dry eye disease therapy LB001.